. Acylcarnitines are determined after alkaline hydrolysis (14, 16, 19, 22 
Materialsand Methods

Principle
The principle of the coupled enzyme reaction for the fluorometric determination of carnitine is shown in Figure   1 . p-NADH produced by the carnitine dehydrogenase 
Enzymes and Chemicals
Purification procedures and properties of carnitine dehydrogenase from Pseudomonas aeruginosa will be described elsewhere. 
Immobilization of Enzymes
The enzymes were immobilized on an AF-Formyl Toyopearl 650 gel (Tosoh Co., Tokyo, Japan) according to Kanamori et al. (23) with some modifications.
We suspended 2 g of the suction-dried gel in 3 mL of NaC1 (0.5 molJL)/ sodium phosphate buffer (0.1 molJL, pH 8.0) containing either 20 mg of diaphorase or 13 mg of carnitine dehydrogenase (two gels). We then added 60 mg of sodium cyanoborohydride (Nacalai Tesque Inc., Kyoto, Japan) and incubated the suspension for 6 h at room temperature, with shaking. We washed the gels with the phosphate buffer and 1.0 mol/L Ths HC1 buffer (pH 7.8). Unreacted formyl groups in the gels were blocked with 5 mL of the Tris buffer and 20 mg of sodium cyanoborohydride for 1 h at room temperature.
After the wash with the Ti-is buffer, we packed each gel in a 4.6 (i.d.) x 35 mm stainless-steel tube. The immobilization yields of carnitine dehydrogenase, diaphorase from B. megaterium, and diaphorase from pig heart were 63.5%, 38.5%, and 34.1%, respectively, calculated by measuring absorbance at 280 nm. Because of insufficient reactivity of the immobilized diaphorase from pig heart, we used the enzyme from B. megaterium in further studies.
Instrumentation and Assay Procedure
The apparatus for a flow-injection system was from Figure 2 . Treated serum samples entered the 100-FL loop injector at 3-mm intervals, were carried by solution 1 at a flow rate of 0.5 mL/min, and were mixed with solution 2 at a flow rate of 0.5 mL/min. While passing through the columns packed with the immobilized enzymes, L-carnitine was converted to resorufin, and the fluorescence intensity of resorufin was monitored (AEX= 560 nm, itEm = 580 nm). Calibration was based on the peak-height method.
Serum Samples and Fractionation Procedure
Serum samples were collected from healthy adults (n = 50) and patients treated with valproic acid (n = 198). The serum samples were frozen at -20 #{176}C. Samples for the determination of free carnitine, total acid-soluble carmtine, and total carnitine were prepared according to Rossle et al. (18) with some modifications. 
Results
Optimization Studies
We studied the reactivities of immobilized enzymes of carnitine dehydrogenase and B. megaterium diaphorase by comparing responses for 1.0 nmol of carnitine and /3-NADH. Because good responses for carnitine were obmined in Tris acetate buffer, we used this buffer to determine optimum pH and concentration of buffer ( Figure 3 ). Carnitine was most effectively converted in 0.6 mol/L Tris acetate buffer, pH 9.5, in the presence of /3-NAD, 1 mol/L, by immobilized carnitine dehydrogenase (Figure 3a) . Resa- zurin (12.5 moI/L) was converted most efficiently to resoruiln by f3-NADH and immobilized B. megaterium diaphorase in 0.6 mol/L Tris acetate buffer, pH 8.75, in the presence of 1 mmol/L f3-NAD. The optimum pH of the coupled enzymes reaction for conversion of carnitine to resorufin was pH 9.0.
High concentrations of the buffer were needed to adjust the deproteinized sample to a less basic pH (pH 8.0) without any hydrolysis of short-chain acylcarnitines in the free carnitine fraction and to adjust the neutralized sample to the optimum pH (pH 9.0) of the coupled enzymes reactions. However, high concentrations of Tris acetate buffer did not affect the reactivities of immobilized carnitine dehydrogenase and B. megaterium diaphorase (Figure 3b) . Concentrations of/3-NAD and resazurin in Tris acetate buffer (0.6 molJL, pH 9.0) affected the reactivities of the immobilized enzymes ( Figure 4 ). Increasing reactivity of immobilized carnitine dehydrogenase toward carnitine, measured by the j3-NADH produced, was obtained by increasing the concentration of (3-NAD.
On the other hand, reactivity of immobilized diaphorase to 13-NADH decreased when /3-NAD exceeded 1.0 mmol/L The combined reactivity of carnitine dehydrogenase and diaphorase, indicated by conversion of carnitine to resorufin, was maximum at a /3-NAD concentration of 1.0 to 2.0 mmol/L. Sufficient reactivity of diaphorase to /3-NADH was obtained at 12.5 to 50 mol of resazurin per liter. Because high concentrations of resazurin increased background interference, the resazurin concentration was maintained at 12.5 molJL.
Calibration curves for carnitine, /3-NADH, and resorufin are shown in Figure 5 . A good linearity of the recorder response to quantities of carrntine was obtained in the range of 0.1 to 1.0 nmol (Figure 5a ). Conversion efficiencies of carnitine to f3-NADH, p-NAI)H to resorufin, and carmtine to resoruiin were 77%, 45%, and 35%, respectively. Proportionality of the recorder responses to carnitine gradually decreased at carnitine quantities >1.0 nmol ( Figure  Sb were not increased by incubation under these conditions.
To study recovery and imprecision, we prepared samples by adding free, acetyl, and palmitoylcarnitine to BSA solution (80 g/L). Analytical recovery and within-run imprecision of the carnitine assay in the corresponding carnitine fractions are shown in Table 1 . Theoretical recoveries of free, total acid-soluble, and total carnitine were obtained in the corresponding carnitine fractions. Withinrun imprecision (n = 12) in each fraction was excellent (CV <3%). Satisfactory between-run imprecision (n = 10) was also obtained (Table 2) . Bilirubin (<500 mg/L), BSA (<100 g/L), and hemoglobin (<100 g/L) did not interfere with carnitine in each fraction.
Carnitine in Serum of Patients Treated with Valproic Acid
Reference values (mean ± 2SD) of free, total acid-soluble, and total carnitine in serum of healthy adults (n = 50) were 53.4 ± 20.6, 60.8 ± 20.2, and 61.3 ± 20.3 pmoliL, respectively.
On the other hand, in the valproic acid-treated patients (n = 198), the values (mean ± 2SD) for free, total acid-soluble, and total carrntines were 44.7 ± 30.1, 52.9 ± Table 1 carnitine values in these patients (9.6 ± 7.6 moIJL) were slightly but insignificantly higher than the reference values (8.9 ± 6.7 anoIJL).
Discussion
The various enzymatic methods involving use of carnitine acetyltransferase have some disadvantages. has good recovery and within-run and between-run imprecision without interference from bilirubin, serum proteins, and hemoglobin. This method also can be applied to the carrntine assay in urine. Carnitine can be quickly determined by injecting samples every 3 mm or less when the immobilized enzymes and the flow-injection system are used.
The large Michaelis constant of carnitine dehydrogenase with regard to carrntine results in a low reactivity to carnitine, with 40% conversion efficiency and a curved calibration line for large amounts of carnitine.
We corrected for the variation of conversion efficiency by measuring standard samples at 20-or 30-assay intervals. Samples of carnitine with concentrations >100 molJL were diluted with Tris acetate buffer (0.2 mol/L, pH 8.0). Reactivity of immobilized carnitine dehydrogenase decreased -10% in one week with >100 assays per day. Immobilized diaphorase was stable for more than three months.
In a flow-injection system, the small sample dilution critically affects the flow injectogram.
To reduce interference from the ultraviolet-absorbing substances in biological samples, we measured the fluorescence intensity of resoruumn at AEX = 560 nm and AErn = 580 nm, rather than that of f3-NADH at AEX = 350 nm and AErn = 450 nm, to lessen the fluorescence quenching. The fluorescence of resorufin was also affected by proteins in serum samples diluted <50-fold; therefore, deproteinization was essential in this method. An automated assay for carnitines, including pretreatment, is being studied with use of a discretetype automated analyzer.
Several patients treated with valproic acid were determined to be carnitine deficient, with low concentrations of and hyperammonemia induced by valproic acid treatment (29) (30) (31) (32) (33) . Carnitine deficiency in anticonvulsant therapy warrants further study.
